Azitra, Inc. (AZTR) Key Statistics & Financial Ratios

Azitra, Inc. (AZTR) — Price $0.16 — Healthcare — Biotechnology — AMEX

Latest reported results:

Key statistics dashboard for Azitra, Inc. (AZTR). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder. ATR-04: Another modified S.

Stock Data

Price$0.16
Market Cap$2M
Enterprise Value-$4.6M
Beta-2.17
ExchangeAMEX
CountryUS

Valuation Multiples

P/E Ratio-0.12
Price / Book0.43
P/S0.00
EV/EBITDA0.88
EV/Sales0.00
EV/FCF0.41
P/FCF-0.15
Earnings Yield-391.55%
FCF Yield-647.01%
Dividend Yield0.00%

Profitability

Gross Margin0.00%
EBIT Margin0.00%
EBITDA Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity-205.45%
Return on Assets-137.65%
Return on Invested Capital-159.45%
Return on Capital Employed-167.20%

Financial Health

Current Ratio4.86
Quick Ratio4.86
Cash Ratio4.40
Debt / Equity0.06
Debt / Assets4.60%
Net Debt / EBITDA1.21
Interest Coverage-1164.70

Per-Share Data

Revenue per share0.00
Book Value per share0.38
Cash per share0.35
FCF per share-0.58
Tangible Book Value per share0.36
Dividend per share0.00

Related companies: ENVB · INDP · JSPR · LIPO · ONCO · REVB · SCNI

Explore sector: Healthcare · Biotechnology

More sections of AZTR: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks